Reviva Pharmaceuticals Holdings, Inc. (RVPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 20.24M |
| Enterprise Value | 6.21M |
| P/E Ratio | -0.26 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.25 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.71 |
| Return On Equity | -2.2 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -19.83M |
| Net Income | -19.86M |
| Diluted EPS | -5.48 |
| Total Cash | 22.19M |
| Total Cash/Share | 3.16 |
| Total Debt | 231,274 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.85 |
| Book Value Per Share | 2.48 |
| 52-Week Change | -95.61 |
| 52-Week High | 17.2 |
| 52-Week Low | 0.26 |
| Moving Average 50 Days | 0.68 |
| Moving Average 200 Days | 5.77 |
| Average Volume | 623,719 |
| Shares Outstanding | 3.41M |
| % Held by Institutions | 52.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 09, 2026 |